HOTH
Hoth Therapeutics·NASDAQ
--
--(--)
--
--(--)
HOTH fundamentals
Hoth Therapeutics (HOTH) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.1669 (YoY +30.46%), met estimates.
Revenue / YoY
0
--
EPS / YoY
-0.1669
+30.46%
Report date
Aug 12, 2025
EPS
Actual | -4.5 | -3.5 | -3.5 | -3.5 | -2.67 | -0.595 | -0.33 | -0.46 | -0.24 | -0.31 | -0.35 | -0.2731 | -0.1669 |
Forecast | -4.25 | -4.25 | -3.375 | -3.625 | -1.96 | -0.625 | -0.51 | -0.445 | -0.24 | -0.305 | -0.37 | -0.18 | -0.1669 |
Surprise | -5.88% | +17.65% | -3.70% | +3.45% | -36.22% | +4.80% | +35.29% | -3.37% | 0.00% | -1.64% | +5.41% | -51.72% | 0.00% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | -- | -- | 0 | 0 | -- | -- | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Hoth Therapeutics next quarter?Did Hoth Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Hoth Therapeutics year over year?What is Hoth Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Hoth Therapeutics's revenue and profit?What were the key takeaways from Hoth Therapeutics's earnings call?What were the key takeaways from Hoth Therapeutics’s earnings call?What is Hoth Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
